Zar Eaglon Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Shaikpet, Telangana, India, established in 2025.
2025 Shaikpet, Telangana, India Active
Last Updated:
Access Report
About Zar Eaglon Pharmaceuticals Private Limited

Zar Eaglon Pharmaceuticals Private Limited, a active private limited company, was established on 25 April 2025 in Shaikpet, Telangana, India. it holds CIN: U21009TS2025PTC197735. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Eaglon Pharmaceuticals Private Limited, Zar Eaglon Pharmaceuticals Private Limited. Its leadership includes Mohd Zulfeqar Hashim Khan (Director), Safia Sheerin (Director), Abdul Jameel (Director). Past directors included Salman Qadeer, Abdul Jameel. It is based at No 15 Shilpi Valley, Enclave Gafoornagar, Shaikpet, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21009TS2025PTC197735

  • Registration Number

    197735

  • Incorporation Date

    25 April 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Months 4 Days
Company report

Zar Eaglon Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zar Eaglon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Zar Eaglon Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohd Zulfeqar Hashim Khan Director 10 Jul 2025 Current
Safia Sheerin Director 25 Apr 2025 Current
Abdul Jameel Director 22 Dec 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zar Eaglon Pharmaceuticals.
Zar Eaglon Pharmaceuticals revenue growth over time
Zar Eaglon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zar Eaglon Pharmaceuticals?

Unlock access to Zar Eaglon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zar Eaglon Pharmaceuticals?

Unlock and access historical data on people associated with Zar Eaglon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zar Eaglon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zar Eaglon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zar Eaglon Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Abdul Jameel was appointed as a Director was appointed as a Director on 22 Dec 2025 & has been associated with this company since 2 months 8 days . was completed.

  • Director Appointment

    Mohd Zulfeqar Hashim Khan was appointed as a Director was appointed as a Director on 10 Jul 2025 & has been associated with this company since 7 months 20 days . was recorded as a recent event.

  • Director Appointment

    The activity Safia Sheerin was appointed as a Director was appointed as a Director on 25 Apr 2025 & has been associated with this company since 10 months 4 days . was completed.

  • Company Incorporation

    The activity Zar Eaglon Pharmaceuticals Private Limited was registered on 25 Apr 2025 with Roc Hyderabad & aged 10 months 4 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zar Eaglon Pharmaceuticals Private Limited?

The CIN of Zar Eaglon Pharmaceuticals Private Limited is U21009TS2025PTC197735.

Where is Zar Eaglon Pharmaceuticals Private Limited headquartered?

Zar Eaglon Pharmaceuticals Private Limited is headquartered at No 15 Shilpi Valley, Enclave Gafoornagar, Shaikpet, Telangana, 500081.

When was Zar Eaglon Pharmaceuticals Private Limited incorporated?

Zar Eaglon Pharmaceuticals Private Limited was incorporated on 25 April 2025.

Who are the current directors of Zar Eaglon Pharmaceuticals Private Limited?

The current directors of Zar Eaglon Pharmaceuticals Private Limited are

Is Zar Eaglon Pharmaceuticals Private Limited a listed company?

Zar Eaglon Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Zar Eaglon Pharmaceuticals Private Limited?

The authorized capital of Zar Eaglon Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available